Get 20% off on all global market reports with code ONLINE20 – stay updated on tariff changes, macroeconomic trends, and more!
What’s Behind the Strong Growth of the Neonatal Point Of Care Testing Market Size in the Last 5 Years?
The market size for neonatal point of care testing has experienced speedy growth in the past few years. It is predicted to expand from $1.16 billion in 2024 to reach $1.32 billion in 2025, which equals a compound annual growth rate (CAGR) of 14.6%.
The exceptional growth seen in the previous period can be credited to a rise in neonatal disorders, an increased requirement for quick diagnostic results, enhanced awareness about risks to neonatal health, climbing rates of preterm births, and an increasing tendency for hospitals to adopt bedside testing.
The market size for neonatal point of care testing is predicted to experience a significant surge in the upcoming years, reaching $2.27 billion in 2029 with a compound annual growth rate (CAGR) of 14.4%. The predicted growth during the prognosis period is due to factors such as the growing desire for personalized neonatal care, the increasing use of portable testing devices, greater emphasis on early disease detection, a heightened focus on decreasing neonatal fatality rates, and an upsurge in investments towards sophisticated diagnostic tools.
Noteworthy trends for the projected period include advancements in biosensor technology, innovations in microfluidic-based diagnostic platforms, funds put towards research and development for multiplex assays, progress in wireless neonatal monitoring systems, and novel developments in point of care molecular testing.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Drivers Are Powering the Rise of the Neonatal Point Of Care Testing Market?
The growth of the neonatal point of care testing market is set to be fueled by the rising demand for remote patient monitoring. This involves utilizing technology to link patients with healthcare professionals over long distances, offering healthcare services remotely.
There’s a surge in demand for such services, particularly for convenient and accessible medical care, which is often necessary for patients in remote or underprivileged areas. The advantage of neonatal point-of-care testing in such a setup is in its ability to deliver immediate bedside diagnostic results.
This enables healthcare providers to swiftly identify and address serious conditions in newborns, without the necessity for a centralized lab. To illustrate, in February 2023, a study by Rock Health, a US-based health technology firm, found that among 8,014 participants, 76% of individuals aged over 55 utilized telemedicine, with a staggering 80% of all participants admitting to have availed care via telemedicine at least once in their life, showing a rise of 8% from the 72% in 2021.
Consequently, the rising demand for remote patient monitoring is likely to boost the neonatal point of care testing market’s growth.
How Is the Neonatal Point Of Care Testing Market Structured Across Key Segments?
The neonatal point of care testing market covered in this report is segmented as
1) By Product: Instruments, Assay
2) By Test Type: Neonatal Bilirubin Testing, Newborn Metabolic Screening, Blood Glucose Testing, Infectious Disease Screening, Electrolyte Testing, Other Test Types
3) By End-Users: Hospitals, Diagnostic Centers, Maternity And Specialty Clinics, Other End-Users
Subsegments:
1) By Instruments: Blood Gas Analyzers, Bilirubinometers, Glucose Meters, Hematology Analyzers, Multiparameter Monitors
2) By Assay: Bilirubin Assays, Glucose Assays, Infectious Disease Assays, Hematology Assays, Cardiac Marker Assays, Electrolyte Assays, Blood Gas Assays
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
How Will Market Trends Drive Strategic Shifts in the Neonatal Point Of Care Testing Sector?
Key businesses in the neonatal point of care testing market are honing in on tactical collaborations as a way to more effectively tap into new markets and customer segments. These strategic partnerships entail pooling together resources and expertise from different organizations to attain mutual business objectives.
For instance, QIAGEN, a company based in the Netherlands that specializes in sample and assay technologies, established a partnership with Genomics England, a company founded in the UK specializing in genomic medicine, in January 2025. This partnership has led to the initiation of the Generation Study, a project aiming to sequence the genomes of 100,000 newborns in England for the purpose of screening over 200 actionable genetic conditions.
QIAGEN will provide the study with exclusive clinically significant variant data for the genes involved in the point-of-care sequencing test. This information will enable swifter interpretation and reporting of sequencing results, which will further promote early discovery and treatment of rare conditions.
The study, which officially commenced in October 2024, focuses on conditions that potentially affect about 3,000 newborns in the UK every year.
Where Is the Neonatal Point Of Care Testing Market Experiencing the Fastest Regional Growth?
North America was the largest region in the neonatal point of care testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The regions covered in neonatal point of care testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Leading Players Shaping the Future of the Neonatal Point Of Care Testing Industry
Major companies operating in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Konica Minolta Inc., Dräger Ag Co. Kg, Bio-Rad Laboratories Inc., Masimo Corporation, QIAGEN Inc., Radiometer Ltd., Contec Medical Systems Co.
Ltd., Owen Mumford Ltd., Nova Biomedical, Heal Force Bio Meditech Holdings Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.I, GINEVRI srl, Hadleigh Health Technologies.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=28277
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
